Integrity Laboratories began testing for SARS-CoV-2 (COVID-19) under Emergency Use Authorization (EUA) on March 23.
Please direct all inquiries to email@example.com for immediate review.
FDA Authorization Letter | FDA EUA Summary
CARES Act Statement
830 Corridor Park Blvd Knoxville, TN 37932
© 2021 Integrity Laboratories. All rights reserved.
Integrity Laboratories is accredited by Clinical Laboratory Improvement Amendments (CLIA), College of American Pathologists (CAP), and licensed by the State of Tennessee Medical Laboratory Board.